Evidence map›Paper›PMID 28346089›Full record

ArticleSLAS discovery : advancing life sciences R & D2017

A Chemogenomic Screening Platform Used to Identify Chemotypes Perturbing HSP90 Pathways.

Fiona M Thomas, Kourtney M Goode, Bartek Rajwa, Andrew A Bieberich, Larisa V Avramova, Tony R Hazbun, V Jo Davisson

Abstract read
In one paragraph

Article in SLAS discovery : advancing life sciences R & D, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Chemical Screening of Nuclear Receptor Modulators.International journal of molecular sciences · 2020
    Review
  2. Screening of Chemical Libraries Using a Yeast Model of Retinal Disease.SLAS discovery : advancing life sciences R & D · 2019
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fiona M Thomas1 Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.
Kourtney M Goode1 Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.
Bartek Rajwa2 Bindley Bioscience Center, Purdue Discovery Park, Purdue University, West Lafayette, IN, USA.
Andrew A Bieberich1 Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.
Larisa V Avramova2 Bindley Bioscience Center, Purdue Discovery Park, Purdue University, West Lafayette, IN, USA.
Tony R Hazbun1 Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.
V Jo Davisson1 Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA.

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI John Tesmer · 1985 to 2026
$43.4M
Integrated Genomewide Analysis of the lpL1 Kinase Signaling NetworkR01GM087461 · NIGMS · PURDUE UNIVERSITY · PI HAZBUN, TONY · 2009 to 2012
$1.1M
Automated spectral data transformations and analysis pipeline for high-throughputR21EB015707 · NIBIB · PURDUE UNIVERSITY · PI RAJWA, BARTLOMIEJ · 2012 to 2013
$410k
High-throughput Chemotyping of Yeast Signature Strains Reflecting Hsp90 BiologyR21NS061667 · NINDS · PURDUE UNIVERSITY · PI DAVISSON, VINCENT JO, HAZBUN, TONY · 2007 to 2007
$153k
NCI NIH HHS P30 CA023168NIBIB NIH HHS R21 EB015707NIGMS NIH HHS R01 GM087461NINDS NIH HHS R21 NS061667
6 · The paper itself

Abstract

Compounds that modulate the heat shock protein (HSP) network have potential in a broad range of research applications and diseases. A yeast-based liquid culture assay that measured time-dependent turbidity enabled the high-throughput screening of different Saccharomyces cerevisae strains to identify HSP modulators with unique molecular mechanisms. A focused set of four strains, with differing sensitivities to Hsp90 inhibitors, was used to screen a compound library of 3680 compounds. Computed turbidity curve functions were used to classify strain responses and sensitivity to chemical effects across the compound library. Filtering based on single-strain selectivity identified nine compounds as potential heat shock modulators, including the known Hsp90 inhibitor macbecin. Haploid yeast deletion strains (360), mined from previous Hsp90 inhibitor yeast screens and heat shock protein interaction data, were screened for differential sensitivities to known N-terminal ATP site-directed Hsp90 inhibitors to reveal functional distinctions. Strains demonstrating differential sensitivity (13) to Hsp90 inhibitors were used to prioritize primary screen hit compounds, with NSC145366 emerging as the lead hit. Our follow-up biochemical and functional studies show that NSC145366 directly interacts and inhibits the C-terminus of Hsp90, validating the platform as a powerful approach for early-stage identification of bioactive modulators of heat shock-dependent pathways.

Indexed as

Drug Screening Assays, AntitumorCell Culture TechniquesCell Line, TumorDrug DiscoveryHaploidyHigh-Throughput Screening AssaysHSP90 Heat-Shock ProteinsHumansMolecular StructurePhenotypeSequence DeletionSignal TransductionSmall Molecule LibrariesStructure-Activity RelationshipHSP90 Heat-Shock ProteinsSmall Molecule Librariesheat shock protein 90high-throughput assayHsp90 C-terminal inhibitorphenotypic screentarget identification

Identifiers

PMID28346089
PMCPMC6521697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.